Cost‐related medication nonadherence among Medicare beneficiaries with cardiovascular disease risk factors: The role of comprehension of the Medicare programme and its prescription drug benefits
Rationale, Aims, and Objectives This study aims to investigate how reported comprehension of the Medicare programme and its prescription drug benefits is associated with cost‐related medication nonadherence (CRN) among Medicare beneficiaries with cardiovascular disease (CVD) risk factors. Methods Th...
Gespeichert in:
Veröffentlicht in: | Journal of evaluation in clinical practice 2023-02, Vol.29 (1), p.136-145 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Rationale, Aims, and Objectives
This study aims to investigate how reported comprehension of the Medicare programme and its prescription drug benefits is associated with cost‐related medication nonadherence (CRN) among Medicare beneficiaries with cardiovascular disease (CVD) risk factors.
Methods
This cross‐sectional study used the 2017 Medicare Current Beneficiary Survey Public Use File data and included Medicare beneficiaries aged ≥65 years who reported having at least one CVD risk factor (i.e., hypertension, hyperlipidemia, diabetes, smoking and obesity) (n = 2821). A survey‐weighted logistic model was used to examine associations between perceived difficulty of understanding the Medicare programme and its prescription drug benefits and CRN, controlling for beneficiaries' demographic (e.g., age) and clinical characteristics (e.g, comorbidities). This study further analyzed five subgroups based on the type of CVD risk factors involved.
Results
Among Medicare beneficiaries with CVD risk factors, 14.4% reported CRN. Medicare beneficiaries with CVD risk factors who reported difficulty understanding the overall Medicare programme and its prescription drug benefits were more likely to report CRN, compared to those who reported easy understanding of the overall Medicare programme (OR = 1.50; 95% CI = 1.11−2.04; p = 0.009) and its prescription drug benefits (OR = 2.01; 95% CI = 1.52−2.66; p |
---|---|
ISSN: | 1356-1294 1365-2753 |
DOI: | 10.1111/jep.13745 |